Cipla
Search results
Business is no more restricted to 4 walls. Proteus Vision is with you always, as an app on your phone. Allows you to perform your important business tasks, anytime, anywhere.
The Sun Story. Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.
We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti ...
Sun Pharmaceuticals | 13,271 followers on LinkedIn. Leadership through focussed research | Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in over 200 counties. It's global presence is supported by 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multicultural workforce comprising over 50 ...
Contact. Sun Pharmaceutical Industries Ltd., SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063. Tel. No.: (+91 22) 4324 4324
4 days ago · Sun Pharma Ltd, part of the pharma space, witnessed a vertical rise of over 17% after hitting a low above Rs 1,300 levels in June 2024 and if the momentum continues, it could hit fresh record highs.Short to medium-term traders can look at buying the stock for a target around Rs 1,700 levels, suggest experts.The Indian market is stabilising after recent gains, as investors take profits and global markets are weak.
Nov 3, 2021 · India business, contributing a third of the company's consolidated revenues, grew on the back of a recovery in non-Covid drug therapies leading to gains for the industry leader. The market is gradually moving back to the pre-Covid levels with Sun growing faster than the industry growth rates.
Jan 31, 2024 · India's largest drugmaker Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in the key domestic and U.S. markets.
Nov 1, 2023 · Sun Pharmaceutical Industries , India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday, driven by strong sales in its domestic and U.S ...
